NSE · SUNPHARMA.NS
Sun Pharmaceutical Industries Limited
₹1,777.70+₹16.70 (+0.95%)
Sun Pharmaceutical Industries Limited’s quoted price sits in the lower half of its reported 52-week range, 13.15% below the high.
Loading market information…
NSE · SURAKSHA.NS · INR
Stock price, dividends, earnings
Quote as of Oct 30, 2026, 10:00 AM UTC. Cached market data; not a live quote.
One-year closing-price history · INR. Historical prices are not a forecast.
Suraksha Diagnostic Ltd.’s quoted price sits in the upper half of its reported 52-week range, 12.36% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Suraksha Diagnostic Ltd.’s forward annual dividend is ₹6.00 per share, paid monthly. The forward yield is 1.9% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
BEHIND THE RESULTS
Suraksha Diagnostic Ltd.’s next earnings report is currently expected on Nov 14, 2026. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow Suraksha Diagnostic Ltd.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Suraksha Diagnostic Limited operates a chain of diagnostic centers in India. It offers pathology testing services, such as microbiology, serology, molecular biology, histopathology, cytopathology, clinical pathology, and haematology; genomics testing, including microarray, noninvasive prenatal, quantitative fluorescent polymerase chain reaction, fluorescence in situ hybridization, and karyotyping; and radiology testing that includes X ray, magnetic resonance imaging, computed tomography scan, USG, DEXA scan, OPG, and mammography. The company also provides Cardiology testing services comprises electrocardiogram, echocardiogram, stress test / treadmill test, wireless holter monitoring, colour doppler, peripheral doppler, and pulmonary function test; gastroenterology, such as upper and lower GI endoscopy, sigmoidoscopy, proctoscopy, colonoscopy, and proctosigmoidoscopy; and neurology testing services, including electroencephalogram, electromyography, and nerve conduction velocity test. In addition, the company provides dental, physiotherapy, immunology & rheumatology, eye, fetal care, ENT, and speciality clinics, as well as home doctor visit services. The company was founded in 1992 and is based in Kolkata, India.
Latest available per-share figures in INR. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 10:02 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
₹1,777.70+₹16.70 (+0.95%)
Sun Pharmaceutical Industries Limited’s quoted price sits in the lower half of its reported 52-week range, 13.15% below the high.
₹9,780.00+₹116.00 (+1.2%)
Divi's Laboratories Limited’s quoted price sits in the upper half of its reported 52-week range, 0.69% below the high.
₹885.20-₹35.90 (-3.9%)
Sigma Advanced Systems Limited’s quoted price sits in the upper half of its reported 52-week range, 24.02% below the high.
₹651.65-₹29.25 (-4.3%)
Bliss GVS Pharma Limited’s quoted price sits in the upper half of its reported 52-week range, 11.93% below the high.
₹19.30-₹1.11 (-5.44%)
Syncom Formulations (India) Limited’s quoted price sits in the upper half of its reported 52-week range, 29.79% below the high.
₹291.90-₹12.05 (-3.96%)
Tarsons Products Limited’s quoted price sits in the upper half of its reported 52-week range, 22.16% below the high.
₹902.00-₹147.10 (-14.02%)
TTK Healthcare Limited’s quoted price sits in the lower half of its reported 52-week range, 27.67% below the high.
₹304.50-₹8.35 (-2.67%)
Bajaj Healthcare Ltd’s quoted price sits in the lower half of its reported 52-week range, 37.72% below the high.
